Molecular Autism

Focusing on the brain, cognition and behavior

Articles

Recent
Most accessed

Resource Identification Initiative

Molecular Autism is participating in the Resource Identification Initiative, a project designed to encourage authors to provide unambiguous identification of three types of key research resources – antibodies, model organisms, and software tools – used in the course of a scientific investigation.

Useful links

Editors-in-Chief

Simon Baron-Cohen, University of Cambridge, UK
Joseph Buxbaum, Icahn School of Medicine at Mount Sinai, New York

New thematic series: Emerging rare genetic and genomic syndromes in autism and developmental delay

View all thematic series

Aims and scope

Molecular Autism is a peer-reviewed, open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications.

We encourage submissions from a range of fields including (but not restricted to) genetics, molecular neurobiology, neuropathology, neuroimaging, cognitive neuroscience, epidemiology, and biomarker discovery. Molecular Autism also publishes articles on screening, diagnosis and classification, including articles that consider subgrouping to refine our understanding of basic mechanisms. Intervention studies are also welcome, especially when considered with respect to revealing causal mechanisms.

Tweets

Featured series: Understanding the links between sex/gender and autism

The male-predominance in the prevalence of autism has many inter-linked implications for understanding the emergence and development of autism. This series, edited by Meng-Chuan Lai, aims to jointly disentangle the complex relationships between sex/gender differences and autism.

Listen to the podcast

Joseph Buxbaum, co-Editor-in-Chief
Joseph Buxbaum is a molecular geneticist and neuroscientist, Director of the Seaver Autism Center for Research and Treatment, and Professor at the Icahn School of Medicine at Mount Sinai. Dr Buxbaum is the founder and co-lead investigator of the Autism Sequencing Consortium, an international collaboration to discover genes for autism. He has also been elected to the prestigious National Academy of Medicine (NAM), in recognition of his important contributions to uncovering the genetic and molecular basis of autism.

Simon Baron-Cohen, co-Editor-in-Chief
Simon Baron-Cohen is Professor of Developmental Psychopathology at the University of Cambridge and Fellow at Trinity College, Cambridge. He is also Director of the Autism Research Centre (ARC) in Cambridge and Director of CLASS (Cambridge Lifespan Asperger Syndrome Service), a clinic for adults with suspected AS.